Levetiracetam for prophylactic treatment of pediatric migraine: A randomized double-blind placebo-controlled trial
- 1 June 2019
- journal article
- research article
- Published by SAGE Publications in Cephalalgia
- Vol. 39 (12) , 1509-1517
Abstract
Few drugs are available for migraine prophylaxis in children. Levetiracetam is a broad-spectrum anti-seizure drug that has been suggested to be effective in reducing adult migraine episodes. We assessed the safety and efficacy of levetiracetam in the prevention of pediatric migraine. A randomized double-blind placebo-controlled trial was performed. Eligible participants were aged 4–17 years old with at least four migrainous episodes monthly or had severe disabling or intolerable episodes. Primary endpoints were the mean changes in monthly frequency and intensity of headaches from the baseline phase to the last month of the double-blind phase. Safety endpoint was the adverse effects reported. Sixty-one participants (31 taking levetiracetam and 30 taking placebo) completed the study. All had a significant reduction in frequency and intensity of episodes that was significantly greater in the levetiracetam arm. Sixty eight percent of individuals in the treatment group reported more than 50% reduction of episodes at the end of the trial compared with 30% in the placebo group (p-value: 0.007). Irritability, day-time sedation, and mild tic were reported. Levetiracetam may be useful in migraine prevention and may decrease migraine episodes and severity. The study is prospectively registered with Iranian Registry of Clinical Trials; IRCT.ir, number IRCT2017021632603N1.Keywords
Funding Information
- The Research Deputy of Tehran University of Medical Sciences (95-01-30-31762)
This publication has 25 references indexed in Scilit:
- Levetiracetam in chronic daily headache: A double-blind, randomised placebo-controlled studyCephalalgia, 2010
- Prevalence of headache and migraine in children and adolescents: a systematic review of population‐based studiesDevelopmental Medicine & Child Neurology, 2010
- Pediatric MigraineNeurologic Clinics, 2009
- Placebo Efficacy in Childhood and Adolescence Migraine: An Analysis of Double-Blind and Placebo-Controlled StudiesCephalalgia, 2009
- Changing Headache from Preschool Age to Puberty. A Controlled StudyCephalalgia, 2007
- Levetiracetam Prophylaxis in Pediatric Migraine—An Open‐Label StudyHeadache: The Journal of Head and Face Pain, 2007
- Psychiatric Comorbidity of MigraineHeadache: The Journal of Head and Face Pain, 2006
- Improvement in Quality of Life and Activity Limitations in Migraine Patients after Prophylaxis. A Prospective Longitudinal Multicentre StudyCephalalgia, 2006
- Prophylactic Treatment of Migraine in Children. Part 2. A Systematic Review of Pharmacological Trials∗Cephalalgia, 2006
- The Medical Costs of Migraine and Comorbid Anxiety and DepressionHeadache: The Journal of Head and Face Pain, 2004